Mizuho stays Outperform rated on Axsome Therapeutics (AXSM) amid scripts decline
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: AXSM) | Delayed: 136.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $136.01 | 52 Week High | $15.74 | |||
| Open | $136.01 | 52 Week Low | $5.37 | |||
| Day High | $136.01 | P/E | N/A | |||
| Day Low | $136.01 | EPS | $0.00 | |||
| Volume | 50 | |||||
